|
|
|
|
||
Re: Zenith - Collaboration to evaluate ZEN-3694 in combination with Talazoparib in TNBC patients; Phase 1b/2 trial expected to initiate 1Q 2019It certainly makes you wonder if Pfizer is going to ready to buy out Zenith with continued good results in prostate CA and promising results in the breast CA trial. Bfw |
return to message board, top of board |